http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022025716-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5ad8562c578b061df7a2c3aee9d0e24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9095a3844c45bc71476e4be38072d158
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-332
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4535
filingDate 2021-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab7f2d8f521ba458dd7d497c5b6704aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9afe2995bbdbe1a5d629ff3ec5047a46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5904cf0e23f43b9b9764c96a9dda9abb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f11f73c386852f95fd603853f7390e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_893994707368bc5d442202ee4fc7cb56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14569c69d4be27d3afd35944fcaadcf3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c83ebe72cc223ec7d87c6c838ada6cc1
publicationDate 2022-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022025716-A1
titleOfInvention Use of 2,3,5-substituted thiophene compound for preventing, alleviation, or treating mastocytosis
abstract The present invention relates to a use of a 2,3,5-substituted thiophene compound for preventing, alleviating, or treating mastocytosis. Being superb in inhibitory rate against mastocytosis proliferation and inhibitory activity against mastocytosis-induced inflammatory responses, the compound can be advantageously used for preventing, alleviating, or treating mastocytosis.
priorityDate 2020-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170096599-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20090130345-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20060127127-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006063773-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6456016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429566663
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5329102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID130358571

Total number of triples: 43.